Literature DB >> 7713792

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

J D Cox, J Stetz, T F Pajak.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7713792     DOI： 10.1016/0360-3016(95)00060-C

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  1100 in total

1.  A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.

Authors:  Jeffrey D Bradley; Jennifer Moughan; Mary V Graham; Roger Byhardt; Ramaswamy Govindan; Jack Fowler; James A Purdy; Jeff M Michalski; Elizabeth Gore; Hak Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-01       Impact factor: 7.038

2.  Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Authors:  Phuc Felix Nguyen-Tan; Qiang Zhang; K Kian Ang; Randal S Weber; David I Rosenthal; Denis Soulieres; Harold Kim; Craig Silverman; Adam Raben; Thomas J Galloway; André Fortin; Elizabeth Gore; William H Westra; Christine H Chung; Richard C Jordan; Maura L Gillison; Marcie List; Quynh-Thu Le
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

3.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

4.  The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.

Authors:  Shohei Komatsu; Takumi Fukumoto; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashima; Yasue Niwa; Masayuki Mima; Osamu Fujii; Ryohei Sasaki; Isamu Yamada; Yuichi Hori; Yoshio Hishikawa; Mitsuyuki Abe; Yonson Ku; Masao Murakami
Journal:  J Gastroenterol       Date:  2011-04-23       Impact factor: 7.527

5.  Postoperative chemoradiotherapy for gallbladder cancer.

Authors:  K Kim; E K Chie; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

6.  Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection.

Authors:  Wen-Sy Tsai; Pao-Shiu Hsieh; Chien-Yuh Yeh; Jy-Ming Chiang; Reiping Tang; Jinn-Shiun Chen; Chung Rong Changchien; Jeng Yi Wang
Journal:  Int J Clin Oncol       Date:  2012-01-20       Impact factor: 3.402

Review 7.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

8.  Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases.

Authors:  Y-X Chen; Z-C Zeng; J Fan; Z-Y Tang; J Zhou; M-S Zeng; J-Y Zhang; J Sun
Journal:  Clin Transl Oncol       Date:  2013-02-05       Impact factor: 3.405

9.  The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.

Authors:  James M Wilson; David P Dearnaley; Isabel Syndikus; Vincent Khoo; Alison Birtle; David Bloomfield; Ananya Choudhury; John Graham; Catherine Ferguson; Zafar Malik; Julian Money-Kyrle; Joe M O'Sullivan; Miguel Panades; Chris Parker; Yvonne Rimmer; Christopher Scrase; John Staffurth; Andrew Stockdale; Clare Cruickshank; Clare Griffin; Emma Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-01-09       Impact factor: 7.038

10.  The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.

Authors:  Nick M Spirtos; Danielle Enserro; Howard D Homesley; Susan K Gibbons; David Cella; Robert T Morris; Koen DeGeest; Roger B Lee; David S Miller
Journal:  Gynecol Oncol       Date:  2019-04-30       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.